We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
-5.85%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$35.2B
AUM Growth
-$3.94B
(-10%)
Cap. Flow
-$1.12B
Cap. Flow
% of AUM
-3.19%
Top 10 Holdings %
Top 10 Hldgs %
20.4%
Holding
1,273
New
111
Increased
414
Reduced
514
Closed
94
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$63.8M |
| 2 |
Align Technology
ALGN
|
+$61.4M |
| 3 |
Stellantis
STLA
|
+$54.4M |
| 4 |
UBS Group
UBS
|
+$49.7M |
| 5 |
Republic Services
RSG
|
+$44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferrari
RACE
|
+$73.1M |
| 2 |
IPG Photonics
IPGP
|
+$62.1M |
| 3 |
Adobe
ADBE
|
+$61.1M |
| 4 |
UnitedHealth
UNH
|
+$56.3M |
| 5 |
Apple
AAPL
|
+$54.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.86% |
| 2 | Healthcare | 17.08% |
| 3 | Financials | 11.33% |
| 4 | Consumer Discretionary | 10.87% |
| 5 | Industrials | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NIU
876
Niu Technologies
NIU
$159M
| $1.23M | ﹤0.01% |
127,146
| – | – |
|
877
Cheniere Energy
LNG
$56B
| $1.22M | ﹤0.01% |
8,816
-2,515
| -22% | -$306K |
|
|
FLG
878
Flagstar Bank National Association
FLG
$5.33B
| $1.22M | ﹤0.01% |
37,867
+32,067
| +553% | +$1.13M |
|
879
Glacier Bancorp
GBCI
$5.89B
| $1.22M | ﹤0.01% |
24,200
-800
| -3% | -$43.2K |
|
880
STAAR Surgical
STAA
$1.13B
| $1.21M | ﹤0.01% |
15,200
-49,200
| -76% | -$3.66M |
|
881
Portland General Electric
POR
$5.58B
| $1.21M | ﹤0.01% |
21,901
+2,800
| +15% | +$147K |
|
|
IAA
882
DELISTED
IAA, Inc. Common Stock
IAA
| $1.2M | ﹤0.01% |
31,300
-2,100
| -6% | -$86.3K |
|
883
Dave & Buster's
PLAY
$239M
| $1.18M | ﹤0.01% |
24,100
-12,200
| -34% | -$488K |
|
884
Prosperity Bancshares
PB
$8.53B
| $1.18M | ﹤0.01% |
17,000
-600
| -3% | -$44.2K |
|
885
Universal Electronics
UEIC
$65.5M
| $1.17M | ﹤0.01% |
37,586
-1,200
| -3% | -$41.5K |
|
|
NUVA
886
DELISTED
NuVasive, Inc.
NUVA
| $1.16M | ﹤0.01% |
20,440
-339,881
| -94% | -$18.1M |
|
887
FNB Corp
FNB
$6.5B
| $1.15M | ﹤0.01% |
92,100
-4,700
| -5% | -$61.9K |
|
|
SYNH
888
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $1.14M | ﹤0.01% |
14,100
-5,000
| -26% | -$423K |
|
889
DXC Technology
DXC
$1.92B
| $1.14M | ﹤0.01% |
34,900
-9,500
| -21% | -$314K |
|
890
Ingredion
INGR
$6.25B
| $1.13M | ﹤0.01% |
13,000
-3,400
| -21% | -$308K |
|
891
CMS Energy
CMS
$20.7B
| $1.13M | ﹤0.01% |
16,100
| – | – |
|
892
QCR Holdings
QCRH
$1.68B
| $1.12M | ﹤0.01% |
19,842
| – | – |
|
893
Best Buy
BBY
$19.6B
| $1.12M | ﹤0.01% |
12,313
-133,977
| -92% | -$13.3M |
|
894
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$47B
| $1.11M | ﹤0.01% |
12,155
+8,680
| +250% | +$794K |
|
895
Petrobras
PBR
$140B
| $1.11M | ﹤0.01% |
75,000
| – | – |
|
896
Alto Ingredients
ALTO
$317M
| $1.09M | ﹤0.01% |
159,700
| – | – |
|
897
Invesco CurrencyShares Euro Currency Trust
FXE
$357M
| $1.08M | ﹤0.01% |
10,544
-1,020
| -9% | -$106K |
|
898
Celestica
CLS
$40B
| $1.07M | ﹤0.01% |
+90,000
| New | +$1.06M |
|
|
MGIC
899
DELISTED
Magic Software Enterprises
MGIC
| $1.06M | ﹤0.01% |
61,553
-4,200
| -6% | -$78.7K |
|
900
Champion Homes
SKY
$4.59B
| $1.06M | ﹤0.01% |
19,300
+15,600
| +422% | +$1.06M |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q1 2022 Portfolio in Review
As of Q1 2022, Axa held 1,273 positions worth $35.2B, down 10% from $39.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Axa withdrew a net $1.12B in Q1 2022, closing 94 positions and reducing 514 holdings. Its most notable exit was Zai Lab, an estimated $21.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in Freshpet worth $30.3M.
- Axa's largest Q1 2022 buy was Freshpet: 294,939 shares worth $30.3M.
- Axa added most to Pfizer in Q1 2022, an estimated $63.8M increase.
- Axa's biggest Q1 2022 reduction was Ferrari, cutting an estimated $73.1M.
- Axa fully exited Zai Lab in Q1 2022, selling an estimated $21.3M.
- Axa's ten largest holdings make up 20% of its $35.2B portfolio in Q1 2022.
- Axa opened 111 new positions and closed 94 in Q1 2022.
- Axa's portfolio value fell 10% quarter-over-quarter to $35.2B.
Based on Axa's 13F filing for Q1 2022, filed 13 May 2022.